Head-to-head comparisons of medication uses, side effects, warnings, and more.
Prolia (denosumab)
Xgeva (denosumab)
Prolia (denosumab)
Xgeva (denosumab)
Summary of Prolia vs. Xgeva
Summary for Monoclonal antibody
Prescription only
Prolia (denosumab) is an injection that's used to treat osteoporosis in adults at high risk of fracture. It's also for those at high risk of fractures from certain cancer medications. It works as a monoclonal antibody called a RANKL inhibitor to strengthen your bones. Prolia (denosumab) is a convenient option because you only need an injection every 6 months. It's injected under the skin by a healthcare professional at a medical office. Side effects include back and muscle pain. It also has a risk of causing dangerously low calcium levels.
Summary for Monoclonal antibody
Prescription only
Xgeva (denosumab) is a RANKL inhibitor that helps prevent the breakdown of bones. It's used to prevent bone problems in adults with certain types of cancer, like breast cancer and prostate cancer, that have spread to the bones. It's also used to lower calcium levels in people who have cancer (hypercalcemia of malignancy). Xgeva (denosumab) is given as an injection under the skin, typically once per month by a healthcare professional (HCP). Common side effects of this medication include fatigue and nausea.
Indications of Prolia vs. Xgeva
Indications for
•Osteoporosis in women who've gone through menopause and at high risk of fracture